Integra LifeSciences (IART) rating downgraded from buy to hold by multiple analysts, with price targets lowered.
Integra LifeSciences (IART) downgraded from buy to hold rating by StockNews.com, while JMP Securities lowered price target from $55.00 to $49.00 and Truist Financial dropped target from $46.00 to $41.00, setting hold ratings. Citigroup upgraded IART from sell to neutral with a $38.00 price target. Nine analysts covering the stock give an average rating of hold and a $44.89 average price target.
May 03, 2024
3 Articles